From viper's venom to drug design: treating hypertension

@article{Patlak2004FromVV,
  title={From viper's venom to drug design: treating hypertension},
  author={Margie Patlak},
  journal={The FASEB Journal},
  year={2004},
  volume={18}
}
  • M. Patlak
  • Published 1 March 2004
  • Medicine
  • The FASEB Journal
Treatment of hypertension has vastly evolved in the past century, moving from difficult and often ineffective low sodium dietary regimens to an arsenal of modern pharmaceuticals. The current use of diuretics, calcium antagonists, blockers, angiotensin converting enzyme (ACE) inhibitors, and angiotensin II receptor blockers (ARB) has restored normal blood pressure levels in nearly all hypertensive patients. It was more than two centuries following the first measurement of blood pressure before… 

Toxin to medicine and bioisosterism in drug development: a study of the discovery and development of ACE inhibitors from snake venom

An account of the discovery, design and development of ACE inhibitors from an academic perspective and possibly, as a guide to future research is presented.

Viper venom for diabetic nephropathy.

Although reductions in urinary albumin excretion were observed, whether RAAS inhibitors offer additional protection over other antihypertensive agents is unclear.

A Review of the Structural and Functional Features of Olmesartan Medoxomil, An Angiotensin Receptor Blocker

The marked antihypertensive efficacy of olmesartan medoxomil may result from a unique pharmacological interaction of the drug with the AT1 receptor, resulting in a potent, long-lasting, dose-dependent blockade of A-II.

Biochemistry of envenomation.

From snake venom toxins to therapeutics--cardiovascular examples.

  • C. KohR. Kini
  • Biology, Chemistry
    Toxicon : official journal of the International Society on Toxinology
  • 2012

Pharmacology of Vasopressin and the Renin–Angiotensin–Aldosterone System

The mechanisms of action of several of these agents will be reviewed, and new agents active in major hormonal pathways, including antidiuretic hormone (ADH) and the rennin–angiotensin system will be introduced.

Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease.

The role of the RAS (renin-angiotensin system) in the pathogenesis of COPD is outlined, including reference to results from fibrotic lung conditions and pulmonary hypertension, and the emerging evidence that ACE inhibition could have a beneficial effect on skeletal muscle function and cardiovascular co-morbidity in COPD patients is addressed.

Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review

Snake venom and human Phospholipase A2 (PLA2) have potential anti-viral activity through inhibition of virion entry into the cells, however, all these require further evaluation in order to establish its role against HIV as an independent one or as a supplement.